Analyst Rating Changes — Upgrades, Downgrades & Price Targets

33545 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

WhenStockChange FirmAnalyst RatingPrice Target
Sep 14
14:16 UTC
RBLX
Roblox
◎ Target Wells Fargo & Company Ken Gawrelski ★★★☆☆ #1138 Overweight $46.00 $64.00+39.1%
Sep 14
14:16 UTC
OXY
Occidental Petroleum
◎ Target Wells Fargo & Company Sam Margolin ★★★★☆ #348 Overweight $79.00 $82.00+3.8%
Sep 14
14:16 UTC
OKTA
Okta
◎ Target Wells Fargo & Company Richard Poland ★★★★☆ #327 Overweight $180.00 $200.00+11.1%
Sep 14
14:16 UTC
NKE
NIKE
◎ Target Citigroup Paul Lejuez ★★☆☆☆ #2317 Neutral $45.00 $39.00-13.3%
Sep 14
14:16 UTC
MUR
Murphy Oil
◎ Target Wells Fargo & Company Sam Margolin ★★★★☆ #348 Equal Weight $41.00 $42.00+2.4%
Sep 14
14:16 UTC
ELF
e.l.f. Beauty
◎ Target Citigroup Filippo Falorni ★★★☆☆ #1087 Buy $100.00 $118.00+18.0%
Sep 14
14:16 UTC
CCL
Carnival
◎ Target Wells Fargo & Company Trey Bowers ★★☆☆☆ #2800 Overweight $38.00 $36.00-5.3%
Sep 14
14:16 UTC
AZO
AutoZone
◎ Target Citigroup Steven Zaccone ★★★☆☆ #1597 Buy $3,700.00 $3,450.00-6.8%
Sep 14
14:16 UTC
ACVA
ACV Auctions
◎ Target Citigroup Ronald Josey ★★☆☆☆ #2236 Neutral $8.50 $10.50+23.5%
Sep 14
13:15 UTC
SGRY
Surgery Partners
◎ Target JPMorgan Chase & Co. Benjamin Rossi ★★★★★ #181 Neutral $14.00 $15.00+7.1%
Sep 14
13:15 UTC
RBLX
Roblox
◎ Target Wedbush Alicia Reese ★★★☆☆ #2184 Neutral $40.00 $48.00+20.0%
Sep 14
13:15 UTC
DK
Delek US
◎ Target TD Cowen Jason Gabelman ★★★★★ #120 Buy $76.00 $90.00+18.4%
Sep 14
13:15 UTC
BKU
BankUnited
◎ Target Hovde Group firm only Outperform $53.00 $52.00-1.9%
Sep 14
13:15 UTC
AVAH
Aveanna Healthcare
◎ Target JPMorgan Chase & Co. Benjamin Rossi ★★★★★ #181 Neutral $8.00 $15.00+87.5%
Sep 14
13:15 UTC
STLA
Stellantis
↓ Downgrade Morgan Stanley firm only Equal Weight Underweight $5.20
Sep 14
13:15 UTC
NKE
NIKE
↓ Downgrade Citigroup Paul Lejuez ★★☆☆☆ #2317 Neutral Negative
Sep 14
13:15 UTC
MKC
McCormick & Company, Incorporated
↓ Downgrade TD Cowen Robert Moskow ★★★☆☆ #1072 Buy Hold $55.00
Sep 14
13:15 UTC
LII
Lennox International
↓ Downgrade Deutsche Bank Aktiengesellschaft firm only Buy Hold $444.00
Sep 14
13:15 UTC
HPE
Hewlett Packard Enterprise
↓ Downgrade Evercore firm only Outperform In-Line $65.00
Sep 14
13:15 UTC
HON
Honeywell International
↓ Downgrade Melius Research firm only Buy Hold $190.00
Sep 14
13:15 UTC
DKS
DICK'S Sporting Goods
↓ Downgrade Robert W. Baird Peter Benedict ★★☆☆☆ #2842 Outperform Neutral $150.00
Sep 14
13:15 UTC
ACN
Accenture
↓ Downgrade Wells Fargo & Company Jason Kupferberg ★★★☆☆ #1281 Overweight Equal Weight $194.00
Sep 14
13:15 UTC
SPRO
Spero Therapeutics
↑ Upgrade Compass Point firm only Neutral
Sep 14
13:15 UTC
SGI
Somnigroup International
↑ Upgrade Stephens Jeff Lick ★☆☆☆☆ #2922 Equal Weight Overweight $66.00 $80.00+21.2%
Sep 14
13:15 UTC
IREN
IREN
↑ Upgrade JPMorgan Chase & Co. Reginald Smith ★★☆☆☆ #2599 Underweight Overweight $46.00 $65.00+41.3%
Sep 14
13:15 UTC
COIN
Coinbase Global
↑ Upgrade Compass Point Ed Engel ★★☆☆☆ #2683 Sell Neutral $130.00 $177.00+36.2%
Sep 14
13:15 UTC
CAVA
CAVA Group
↑ Upgrade Compass Point firm only Neutral
Sep 14
13:15 UTC
CAPR
Capricor Therapeutics
↑ Upgrade B Riley firm only Neutral Buy
Sep 14
13:15 UTC
CAPR
Capricor Therapeutics
↑ Upgrade B. Riley Financial Madison El-Saadi not yet tracked Neutral Buy $21.00
Sep 14
13:15 UTC
BLSH
Bullish
↑ Upgrade Compass Point Ed Engel ★★☆☆☆ #2683 Neutral Buy $30.00 $51.00+70.0%
Sep 14
12:15 UTC
SPRO
Spero Therapeutics
◎ Target HC Wainwright Raghuram Selvaraju not yet tracked Buy $5.00 $6.00+20.0%
Sep 14
12:15 UTC
RBLX
Roblox
◎ Target Bank of America Omar Dessouky ★★★☆☆ #1028 Neutral $44.00 $48.00+9.1%
Sep 14
12:15 UTC
NTRP
NextTrip
◎ Target Ascendiant Capital Markets Edward Woo ★☆☆☆☆ #3079 Buy $7.50 $7.75+3.3%
Sep 14
12:15 UTC
DUOT
Duos Technologies Group
◎ Target Ascendiant Capital Markets Edward Woo ★☆☆☆☆ #3079 Buy $22.00 $24.00+9.1%
Sep 14
12:15 UTC
STLA
Stellantis
↓ Downgrade Morgan Stanley firm only Equal Weight Underweight
Sep 14
12:15 UTC
ADUS
Addus HomeCare
↓ Downgrade Citigroup firm only Market Outperform Neutral
Sep 14
12:15 UTC
FDMT
4D Molecular Therapeutics
↑ Upgrade Cantor Fitzgerald Josh Schimmer not yet tracked Neutral Overweight $20.00
Sep 14
12:15 UTC
CHYM
Chime Financial
↑ Upgrade Rothschild & Co Redburn Harry Bartlett not yet tracked Neutral Buy $46.00
Sep 14
11:15 UTC
FCNCA
First Citizens BancShares
↓ Downgrade UBS Group firm only Buy Neutral
Sep 14
11:15 UTC
ACN
Accenture
↓ Downgrade Wells Fargo & Company Jason Kupferberg ★★★☆☆ #1281 Overweight Positive
Sep 14
11:15 UTC
GEV
GE Vernova
↑ Upgrade The Goldman Sachs Group firm only Buy Market Outperform
Sep 14
11:15 UTC
CIZN
Citizens
↑ Upgrade The Goldman Sachs Group firm only Market Outperform
Sep 14
10:15 UTC
TRN
Trainline
◎ Target Canaccord Genuity Group firm only Buy GBX 311 GBX 333+7.1%
Sep 14
10:15 UTC
MPE
M.P. Evans Group
◎ Target Canaccord Genuity Group firm only Buy GBX 1,900 GBX 2,500+31.6%
Sep 14
10:15 UTC
IOF
Iofina
◎ Target Canaccord Genuity Group firm only Buy GBX 65 GBX 70+7.7%
Sep 14
10:15 UTC
CER
Cerillion
◎ Target Canaccord Genuity Group firm only Buy GBX 2,060 GBX 1,760-14.6%
Sep 14
10:15 UTC
SAUHY
Straumann
↑ Upgrade The Goldman Sachs Group firm only Neutral Buy
Sep 14
09:15 UTC
DLN
Derwent London
◎ Target Berenberg Bank firm only Buy GBX 2,210 GBX 2,071-6.3%
Sep 14
09:15 UTC
ANTO
Antofagasta
↑ Upgrade Berenberg Bank firm only Buy GBX 4,400
Sep 14
06:15 UTC
RCI
Rogers Communication
↑ Upgrade Desjardins firm only Hold Buy
🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.
A free account unlocks the full daily feed.
‹ Prev 38 / 671 Next ›

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.